Nanalysis Scientific Corp.
NSCIF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $45,495 | $28,466 | $24,821 | $16,043 |
| % Growth | 59.8% | 14.7% | 54.7% | – |
| Cost of Goods Sold | $32,749 | $24,495 | $14,352 | $5,803 |
| Gross Profit | $12,746 | $3,971 | $10,469 | $10,240 |
| % Margin | 28% | 13.9% | 42.2% | 63.8% |
| R&D Expenses | $544 | $679 | $1,465 | $643 |
| G&A Expenses | $9,673 | $11,041 | $12,414 | $6,140 |
| SG&A Expenses | $11,294 | $12,393 | $14,350 | $8,283 |
| Sales & Mktg Exp. | $1,621 | $1,352 | $1,936 | $2,143 |
| Other Operating Expenses | $4,353 | $4,365 | $4,564 | $2,505 |
| Operating Expenses | $16,191 | $15,592 | $20,379 | $11,431 |
| Operating Income | -$3,445 | -$11,621 | -$9,910 | -$1,191 |
| % Margin | -7.6% | -40.8% | -39.9% | -7.4% |
| Other Income/Exp. Net | -$10,190 | -$5,174 | -$489 | -$581 |
| Pre-Tax Income | -$13,635 | -$16,795 | -$10,399 | -$1,772 |
| Tax Expense | -$22 | -$11 | -$484 | $0 |
| Net Income | -$13,613 | -$16,784 | -$9,915 | -$1,772 |
| % Margin | -29.9% | -59% | -39.9% | -11% |
| EPS | -0.12 | -0.16 | -0.11 | -0.033 |
| % Growth | 25% | -45.5% | -229.3% | – |
| EPS Diluted | -0.12 | -0.16 | -0.11 | -0.033 |
| Weighted Avg Shares Out | 110,639 | 99,176 | 91,010 | 59,067 |
| Weighted Avg Shares Out Dil | 110,639 | 99,176 | 92,476 | 70,402 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $76 | $2 |
| Interest Expense | $1,345 | $284 | $152 | $0 |
| Depreciation & Amortization | $4,626 | $4,666 | $4,649 | $2,567 |
| EBITDA | -$7,664 | -$8,848 | -$5,261 | $1,376 |
| % Margin | -16.8% | -31.1% | -21.2% | 8.6% |